Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)

Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5) Publisher Pubmed

Gharaylou Z^{1, 7} ; Tafakhori A² ; Agah E^{3, 4} ; Aghamollaii V⁵ ; Kebriaeezadeh A⁶ ; Hadjighassem M^{1, 7, 8}

Source: CNS Drugs Published:2019

Abstract

Related Docs

View other Related Docs

1. Corrigendum to “Smart Multilayer Chitosan-Based Nanofibers for Burn Wounds: Ph-Responsive Dual Release of Diclofenac Sodium & Hamamelis Virginiana Extract: From Design to in Vitro & in Vivo Evaluation” [Int. J. Biol. Macromol. Volume 320 (2025) Article No. 145826] (International Journal of Biological Macromolecules (2025) 320(P3), (S0141813025063810), (10.1016/J.Ijbiomac.2025.145826)), International Journal of Biological Macromolecules (2025)

2. Corrigendum to ‘Arsenic and Type 2 Diabetes: Revealing the Environmental Exposure Relationship Through Effective Factors - a Systematic Review’ [Res. Eng. 22 (2024) 102054] (S2590123024003086), (10.1016/J.Rineng.2024.102054), Results in Engineering (2024)

3. Correction To: Eco-Hydrologic Stability Zonation of Dams and Power Plants Using the Combined Models of Smce and Cequalw2 (Applied Water Science, (2021), 11, 7, (109), 10.1007/S13201-021-01427-Z), Applied Water Science (2022)

Experts (# of related papers)

View all Related Experts

Reza Negarandeh (1)

Saeid Amanpour (1)

Style	Citing Format
MLA	Gharaylou Z, et al.. "Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)." CNS Drugs, vol. 33, no. 8, 2019, pp. 839-.
APA	Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M (2019). Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5). CNS Drugs, 33(8), 839-.
Chicago	Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M. "Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)." CNS Drugs 33, no. 8 (2019): 839-.
Harvard	Gharaylou Z et al. (2019) 'Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)', CNS Drugs, 33(8), pp. 839-.
Vancouver	Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M. Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5). CNS Drugs. 2019;33(8):839-.
BibTex	@article{ author = {Gharaylou Z and Tafakhori A and Agah E and Aghamollaii V and Kebriaeezadeh A and Hadjighassem M}, title = {Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)}, journal = {CNS Drugs}, volume = {33}, number = {8}, pages = {839-}, year = {2019} }
RIS	TY - JOUR AU - Gharaylou Z AU - Tafakhori A AU - Agah E AU - Aghamollaii V AU - Kebriaeezadeh A AU - Hadjighassem M TI - Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5) JO - CNS Drugs VL - 33 IS - 8 SP - 839 EP - PY - 2019 ER -

Style

Citing Format

MLA

Gharaylou Z, et al.. "Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)." CNS Drugs, vol. 33, no. 8, 2019, pp. 839-.

APA

Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M (2019). Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5). CNS Drugs, 33(8), 839-.

Chicago

Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M. "Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)." CNS Drugs 33, no. 8 (2019): 839-.

Harvard

Gharaylou Z et al. (2019) 'Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)', CNS Drugs, 33(8), pp. 839-.

Vancouver

Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M. Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5). CNS Drugs. 2019;33(8):839-.

BibTex

@article{ author = {Gharaylou Z and Tafakhori A and Agah E and Aghamollaii V and Kebriaeezadeh A and Hadjighassem M}, title = {Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)}, journal = {CNS Drugs}, volume = {33}, number = {8}, pages = {839-}, year = {2019} }

RIS

TY - JOUR
AU - Gharaylou Z
AU - Tafakhori A
AU - Agah E
AU - Aghamollaii V
AU - Kebriaeezadeh A
AU - Hadjighassem M
TI - Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an Nkcc1 Inhibitor, in Patients With Drug-Resistant Epilepsy (Cns Drugs, (2019), 33, 3, (283-291), 10.1007/S40263-019-00607-5)
JO - CNS Drugs
VL - 33
IS - 8
SP - 839
EP -
PY - 2019
ER -

Science Communicator Platform

Authors

Abstract